Journal of Hematology & Oncology

official impact factor 2.93

Open Access

Temozolomide and cisplatin in relapsed/refractory acute leukemia

Karen Seiter*, Sreedhar Katragadda, Doris Ponce, Muhammad Rasul and Nasir Ahmed

Journal of Hematology & Oncology 2009, 2:21 doi:10.1186/1756-8722-2-21

Accesses  

  • Last 30 days: 67 accesses
  • Last 365 days: 653 accesses
  • All time: 2777 accesses